Cargando…

Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”

BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Simon, Laniado, Marc, Montgomery, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433361/
https://www.ncbi.nlm.nih.gov/pubmed/28328188
http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145
_version_ 1783236836629413888
author Robinson, Simon
Laniado, Marc
Montgomery, Bruce
author_facet Robinson, Simon
Laniado, Marc
Montgomery, Bruce
author_sort Robinson, Simon
collection PubMed
description BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a peripheral zone acinar volume and density. With the ratio to the whole gland, we can better predict high grade and all grade cancer. We can model the gland into its acinar and stromal elements. This new “prostatocrit” model could offer more accurate nomograms for biopsy. MATERIALS AND METHODS: 674 patients underwent TRUS and biopsy. Whole gland and zonal volumes were recorded. We compared ratio and acinar volumes when added to a “clinic” model using traditional PSA density. Univariate logistic regression was used to find significant predictors for all and high grade cancer. Backwards multiple logistic regression was used to generate ROC curves comparing the new model to conventional density and PSA alone. OUTCOME AND RESULTS: Prediction of all grades of prostate cancer: significant variables revealed four significant “prostatocrit” parameters: log peripheral zone acinar density; peripheral zone acinar volume/whole gland acinar volume; peripheral zone acinar density/whole gland volume; peripheral zone acinar density. Acinar model (AUC 0.774), clinic model (AUC 0.745) (P=0.0105). Prediction of high grade prostate cancer: peripheral zone acinar density (“prostatocrit”) was the only significant density predictor. Acinar model (AUC 0.811), clinic model (AUC 0.769) (P=0.0005). CONCLUSION: There is renewed use for ratio and “prostatocrit” density of the peripheral zone in predicting cancer. This outperforms all traditional density measurements.
format Online
Article
Text
id pubmed-5433361
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-54333612017-05-30 Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit” Robinson, Simon Laniado, Marc Montgomery, Bruce Int Braz J Urol Original Article BACKGROUND: Prostate-specific antigen densities have limited success in diagnosing prostate cancer. We emphasise the importance of the peripheral zone when considered with its cellular constituents, the “prostatocrit”. OBJECTIVE: Using zonal volumes and asymmetry of glandular acini, we generate a peripheral zone acinar volume and density. With the ratio to the whole gland, we can better predict high grade and all grade cancer. We can model the gland into its acinar and stromal elements. This new “prostatocrit” model could offer more accurate nomograms for biopsy. MATERIALS AND METHODS: 674 patients underwent TRUS and biopsy. Whole gland and zonal volumes were recorded. We compared ratio and acinar volumes when added to a “clinic” model using traditional PSA density. Univariate logistic regression was used to find significant predictors for all and high grade cancer. Backwards multiple logistic regression was used to generate ROC curves comparing the new model to conventional density and PSA alone. OUTCOME AND RESULTS: Prediction of all grades of prostate cancer: significant variables revealed four significant “prostatocrit” parameters: log peripheral zone acinar density; peripheral zone acinar volume/whole gland acinar volume; peripheral zone acinar density/whole gland volume; peripheral zone acinar density. Acinar model (AUC 0.774), clinic model (AUC 0.745) (P=0.0105). Prediction of high grade prostate cancer: peripheral zone acinar density (“prostatocrit”) was the only significant density predictor. Acinar model (AUC 0.811), clinic model (AUC 0.769) (P=0.0005). CONCLUSION: There is renewed use for ratio and “prostatocrit” density of the peripheral zone in predicting cancer. This outperforms all traditional density measurements. Sociedade Brasileira de Urologia 2017 /pmc/articles/PMC5433361/ /pubmed/28328188 http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Robinson, Simon
Laniado, Marc
Montgomery, Bruce
Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title_full Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title_fullStr Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title_full_unstemmed Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title_short Prostate specific antigen and acinar density: a new dimension, the “Prostatocrit”
title_sort prostate specific antigen and acinar density: a new dimension, the “prostatocrit”
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433361/
https://www.ncbi.nlm.nih.gov/pubmed/28328188
http://dx.doi.org/10.1590/S1677-5538.IBJU.2016.0145
work_keys_str_mv AT robinsonsimon prostatespecificantigenandacinardensityanewdimensiontheprostatocrit
AT laniadomarc prostatespecificantigenandacinardensityanewdimensiontheprostatocrit
AT montgomerybruce prostatespecificantigenandacinardensityanewdimensiontheprostatocrit